Thyrocare Technologies Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
- Paid Up Capital ₹ 52.95 Cr
- Company Age 25 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 45.00 Cr
- Satisfied Charges ₹ 0.46 M
- Revenue Growth -13.55%
- Profit Growth -62.53%
- Ebitda -51.48%
- Net Worth 0.07%
- Total Assets 2.46%
About Thyrocare Technologies
Thyrocare Technologies Limited (TTL) is a leading Public Limited Indian Non-Government Company incorporated in India on 28 January 2000 and has a history of 25 years. Its registered office is in Thane, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 539871 and on the National Stock Exchange(NSE) under THYROCARE.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 52.95 Cr.
The company currently has active open charges totaling ₹45.00 Cr. The company has closed loans amounting to ₹0.46 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Thyrocare Technologies Limited India are Ramjee Dorai as Company Secretary, Rahul Guha as Ceo, and Alok Jagnani as Cfo. Gopal Hegde, Neetin Desai, Hardik Dedhia, and Six other members serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
Industry
What products or services does Thyrocare Technologies Limited offer?
Thyrocare Technologies Limited offers a wide range of products and services, including Barcode, Barcode Label, Medical Treatment Services, Infertility Treatment, Animal Treatment Services, Veterinary Doctors, Cancer Treatment, Industrial Automation Systems, Automation Systems, Insurance Service.
Who are the key members and board of directors at Thyrocare Technologies?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Guha
|
Managing Director | 04-May-2022 | Current |
|
Ramjee Dorai
|
Company Secretary | 03-Sep-2014 | Current |
| Alok Jagnani | CFO | 09-Aug-2023 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Neetin Desai
|
Director | 20-Sep-2014 | Current |
|
Dharmil Sheth
|
Director | 02-Sep-2021 | Current |
|
Gopal Hegde
|
Director | 21-Aug-2014 | Current |
|
Hardik Dedhia
|
Director | 02-Sep-2021 | Current |
|
Indumati Gopinathan
|
Director | 12-Aug-2017 | Current |
|
Prapti Gilada
|
Director | 14-Jul-2023 | Current |
Financial Performance of Thyrocare Technologies.
Thyrocare Technologies Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.55% decrease. The company also saw a substantial fall in profitability, with a 62.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thyrocare Technologies?
In 2023, Thyrocare Technologies had a promoter holding of 71.14% and a public holding of 28.86%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Stemrx Bioscience Solutions Private LimitedNeetin Desai is a mutual person
-
Solar Magic Private LimitedDharmil Sheth is a mutual person
-
Nueclear Healthcare LimitedGopal Hegde, Hardik Dedhia and 5 more are mutual person
-
Api Holdings LimitedHardik Dedhia and Dhaval Shah are mutual person
-
Docon Technologies Private LimitedHardik Dedhia and Dhaval Shah are mutual person
-
Shree Simba Chemist LlpHardik Dedhia is a mutual person
Charges (Loans)
₹45.00 Cr
₹0.05 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 45.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2023 | Hdfc Bank Limited | ₹45.00 Cr | Open |
| 29 Apr 2002 | Uti Bank Ltd; | ₹0.46 M | Satisfied |
How Many Employees Work at Thyrocare Technologies?
Thyrocare Technologies has a workforce of 1758 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thyrocare Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thyrocare Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
